ESG News For SHANGHAI NO.1 PHARMACY CO., LTD.
These sites contributed news to this page:
-
Recap of CSR stories on Business Wire
-
$5 billion bond is the largest of its kind from any sector and the first issued by a generic medicines companyThe bond is tied to targets that include improving access to medicines in low- and middle-income countries (LMICs) and reducing greenhouse gas (GHG) emissions
We use cookies to improve the usability of our site and to analyze traffic patterns so we can improve our utility. Please agree to our use of cookies.